FGF23 and myocardial infarction: In a post hoc analysis of the EVOLVE trial (vide infra) by Moe et al. among nearly three thousand patients on dialysis, FGF23 was statistically significantly associated with the incidence of myocardial infarction [81], an association also found in CKD [45, 75] and in the general population [82, 83].